The Latest Cardiac and Vascular News
– More than 3 million people in the US have severe hypertriglyceridemia – The CORE Phase 3 clinical study further expands Ionis’ late-stage pipeline and is the second Phase 3 clinical study in Ionis’ broad olezarsen development program – Olezarsen is one of Ionis’ wholly owned medicines the company plans […]
SEOUL, South Korea, Nov. 2, 2021 /PRNewswire/ — South Korean artificial intelligence (AI) developer, VUNO inc. announced that the Korean Ministry of Food and Drug Safety (KFDA) has designated the company’s artificial intelligence-based electrocardiogram (ECG) analysis software VUNO Med®-DeepECG™ as the ministry’s 16th Breakthrough Device. Using deep learning, the software analyzes ECG data […]
FRISCO, Texas, Nov. 2, 2021 /PRNewswire/ — Argon Medical Devices, Inc., a global manufacturer of specialty devices for Interventional Radiology, Vascular Surgery, and Interventional Cardiology, formally announced the launch of two unique portal vein access sets intended for transjugular liver access in diagnostic and interventional procedures. The SCORPION® Portal Vein Access Series addresses […]
November 2, 2021 Philips debuts three new solutions in the North American market that will help drive procedural innovation and workflow efficiency, adding to the company’s ecosystem of interventional imaging systems, and diagnostic and therapeutic devices New clinical data presented at TCT 2021: five-year outcomes of iFR-SWEDEHEART trial and new large-scale […]
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 29, 2021 it granted stock options to purchase an aggregate of 68,550 shares of common stock to 8 new employees, whose employment commenced in October 2021, as a material inducement to […]
– Recently Announced Transformative Plan to Align Operational and Expense Structure to the Current Environment and Position for Long-Term Growth – – Unprecedented CLEAR Outcomes Study Remains On-Track for Complete Major Adverse Cardiac Events (MACE) Accumulation in 2H 2022; Achieved 80% MACE Accumulation in October – – U.S. Net Product Revenue […]
Vivek Walimbe, Ph.D., former VP for Baxter Healthcare, to lead development of intracoronary imaging product and expand portfolio Farzad Parsaie, with three decades of med device leadership, to oversee Quality and Regulatory Affairs BEDFORD, Mass.–(BUSINESS WIRE)–SpectraWAVE, Inc., a pre-commercial medical imaging company focused on optical and computational insights for the […]
HU6 was well tolerated and increased resting energy expenditure Dose dependent weight loss and an improvement in metabolic parameters were also observed, despite the study not being powered to demonstrate them Enrollment for a Phase 2a Metabolic Trial of HU6 has completed with topline data expected in Q1 2022 HU6 […]
David Seth Feldman, MD, PhD, FACC, FAHA, named new Section Chief of Advanced Heart Failure Treatment and Transplantation NEWARK, N.J., Nov. 1, 2021 /PRNewswire/ — Newark Beth Israel Medical Center, an RWJBarnabas Health facility, has named David Seth Feldman, MD, PhD, FACC, FAHA, the new Section Chief of Advanced Heart Failure Treatment and Transplantation. […]
Breakthrough CCM Therapy Now Being Implemented in China MARLTON, N.J., Nov. 01, 2021 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, today announced the first implantation of a patient in China with its innovative Optimizer system delivering CCM […]
